Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRhythm HoldingsIRTC -2.70%72 Cash Ratio is 4.17 as of Mar. 2026, which is 16% above its 10-year median of 3.58. GuruFocus rates IRTC with a GF Score™ of 72/100 and a GF Value™ of $164.62 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 841 Medical Devices & Instruments companies, iRhythm Holdings ranks better than 83.71% on this metric.
iRhythm Holdings has a Cash Ratio of 4.17. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for iRhythm Holdings's Cash Ratio or its related term are showing as below:
IRTC'
s Cash Ratio Range Over the Past 10 Years
Min: 0.62 Med: 3.58 Max: 8.71
Current: 4.17
During the past 12 years, iRhythm Holdings's highest Cash Ratio was 8.71. The lowest was 0.62. And the median was 3.58.
IRTC's Cash Ratio is ranked better than 83.71% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs IRTC: 4.17
iRhythm Holdings (NAS:IRTC) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
iRhythm Holdings Cash Ratio Related Terms
iRhythm Holdings Cash Ratio Historical Data
* Premium members only.
The historical data trend for iRhythm Holdings's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, iRhythm Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Holdings Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's Cash Ratio distribution charts can be found below:
* The bar in red indicates where iRhythm Holdings's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Holdings (IRTC) has a Cash Ratio of 4.17 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on iRhythm Holdings and its competitors. This is 16% above median its historical median of 3.58. Over the past decade, iRhythm Holdings' Cash Ratio has ranged from 0.62 to 8.71. According to the industry distribution chart, iRhythm Holdings ranks #137 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 16.3%.
Is iRhythm Holdings' Cash Ratio too high?
iRhythm Holdings' current Cash Ratio of 4.17 is 16% above median its 10-year median of 3.58. Over the past 10 years, this metric has ranged from a low of 0.62 to a high of 8.71. The Medical Devices & Instruments industry median Cash Ratio is 0.97. iRhythm Holdings' value of 4.17 is 329.9% above this industry median. Based on the distribution chart, iRhythm Holdings ranks #137 out of 841 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, iRhythm Holdings has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Cash Ratio compare to HAE and LIVN?
According to the Medical Devices & Instruments industry distribution chart, iRhythm Holdings ranks #137 out of 841 companies for Cash Ratio. This places iRhythm Holdings in the top 16% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.97. iRhythm Holdings' value of 4.17 is 329.9% above this benchmark. Historically, iRhythm Holdings' own Cash Ratio has ranged from 0.62 to 8.71 over the past decade. While the company's 10-year median is 3.58 vs. the industry median of 0.97, iRhythm Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRhythm Holdings's current Cash Ratio of 4.17 is 329.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on iRhythm Holdings and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRhythm Holdings's current Cash Ratio is 4.17, which is 16% above median its own 10-year median of 3.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Significantly Undervalued. The stock's GF Value™ is $164.62, compared to a current price of $106.07 — trading 35.6% below its estimated fair value. The current Cash Ratio is 4.17, which is 16% above median its 10-year median of 3.58 and 329.9% above the Medical Devices & Instruments industry median of 0.97. iRhythm Holdings' overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current Cash Ratio is 4.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRhythm Holdings (IRTC) Overvalued in 2026?
Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued.
The current stock price of $106.07 is trading 35.6% below its estimated GF Value™ of $164.62.
GuruFocus considers iRhythm Holdings to be Significantly Undervalued.
Key valuation signals for IRTC:
Cash Ratio: 4.17 (16% above median its 10-year median of 3.58)
GF Value™: $164.62 vs. price of $106.07 (35.6% below fair value)
Industry Position: 329.9% above the Medical Devices & Instruments median (#137 of 841)
No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
72GF Score
Get the complete analysis for IRTC
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRTC has been successfully added to your 
